A comparison of the incidence of the myelodysplastic syndrome and acute myeloid leukaemia following melphalan and cyclophosphamide treatment for myelomatosis. A report to the Medical Research Council's working party on leukaemia in adults.

Twelve of 648 patients in the Medical Research Council's first two trials in myelomatosis have developed myelodysplasia or acute leukaemia. This corresponds to a 5-year actuarial prevalence of 3% and an 8-year prevalence of 10%. Patients were randomised to treatment with either melphalan or cyc...

Descripción completa

Detalles Bibliográficos
Autores principales: Cuzick, J., Erskine, S., Edelman, D., Galton, D. A.
Formato: Texto
Lenguaje:English
Publicado: Nature Publishing Group 1987
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001731/
https://www.ncbi.nlm.nih.gov/pubmed/3300761

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001731/
https://www.ncbi.nlm.nih.gov/pubmed/3300761

Ejemplares similares